Get informed when a big investor buys or sells
+ FollowOvervalued by 24.4% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.11 Billion |
|---|---|
| Enterprise Value | $1.04 Billion |
| Annual dividend | $0.03 |
| Dividend yield | 0.38% |
| Earnings per Share | $0.1 |
| Beta | 0.6 |
| Outstanding Shares | 134,360,900 |
| P/E Ratio | 156.37 |
|---|---|
| PEG | -193.95 |
| Price to Sales | 6.67 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 4.57 |
| Enterprise Value to EBIT | 297.65 |
| Enterprise Value to Net Income | 131 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deploym...